Virtual Visits at Brigham and Women's Hospital

NCT03592355 | Terminated

• 1 other identifier: 2018P000452
• Study Type: interventional
• Target: 77
• Locations: 1 country
• Sites: 1

Brief Summary

Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm). The investigators plan to enroll no more than 200 clinicians. Any clinician in a department selected by the Brigham Health Virtual Care team for access to virtual visits is eligible, unless s/he saw less than 20 patients monthly over the last 6 months. The Brigham Health Virtual Care team will onboard all clinicians and provide virtual visit support as per their usual protocol. The primary study endpoint is third-available appointment, a well-adopted measure of access. Other secondary endpoints revolve around continuity, efficiency, utilization, safety, cost, and patient experience.

Conditions

Heart Failure; Hypertension; Diabetes Mellitus; Stroke; BPH; Hyperlipidemia

Keywords

virtual care; virtual visit; telemedicine

Outcome Measures

Primary Outcomes (1)

• Days until third available appointment

  Number of days until the third available routine appointment, obtained at 12 o'clock each Friday (embargoed appointments not included). The mean of all of the weeks is a clinician's average number of days until the third available routine appointment.

  Through study completion, an average of 6 months

Secondary Outcomes (20)

• Days until first available appointment

  Through study completion, an average of 6 months

• Future capacity: percentage of open appointment slots

  Through study completion, an average of 6 months

• Frequency of visits with the usual provider of care

  Through study completion, an average of 6 months

• Continuity of care index

  Through study completion, an average of 6 months

• No show rate

  Through study completion, an average of 6 months

Study Arms (2)

Intervention

EXPERIMENTAL

If enrolled in the intervention arm, the following steps will occur: * The Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process. * The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform.

Other: Virtual Visit

Control

NO INTERVENTION

If enrolled in the control arm, the following steps will occur: * Three months from the time of the follow-up email, the Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process. * The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform.

Interventions

Virtual Visit OTHER

Clinicians will have a synchronous video visit with their patients.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Clinician whose department is chosen for virtual visit rollout

You may not qualify if:

• Clinician who saw on average fewer than 20 patients monthly over the past 6 months
• Clinician who opts out of virtual visits

Sponsors & Collaborators

• Brigham and Women's Hospital: lead

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (3)

• Wootton R. Twenty years of telemedicine in chronic disease management--an evidence synthesis. J Telemed Telecare. 2012 Jun;18(4):211-20. doi: 10.1258/jtt.2012.120219.

  PMID: 22674020 BACKGROUND

• McLean S, Sheikh A, Cresswell K, Nurmatov U, Mukherjee M, Hemmi A, Pagliari C. The impact of telehealthcare on the quality and safety of care: a systematic overview. PLoS One. 2013 Aug 19;8(8):e71238. doi: 10.1371/journal.pone.0071238. eCollection 2013.

  PMID: 23977001 BACKGROUND

• Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med. 2016 Jul 14;375(2):154-61. doi: 10.1056/NEJMra1601705. No abstract available.

  PMID: 27410924 BACKGROUND

MeSH Terms

Conditions

Heart Failure; Hypertension; Diabetes Mellitus; Stroke; Hyperlipidemias

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Dyslipidemias; Lipid Metabolism Disorders

Study Officials

• David Levine, MD, MPH, MA

  Principal Investigator

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Physician

Model Details: Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm).

Study Record Dates

• First Submitted: May 14, 2018
• First Posted: July 19, 2018
• Study Start: April 13, 2018
• Primary Completion: March 1, 2020
• Study Completion: March 1, 2020
• Last Updated: September 22, 2021

Record last verified: 2021-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)